Background Cytomegalovirus (CMV) is endemic worldwide, with marked differences in the seroprevalence rates between countries. The aim of this study was to analyze the seroprevalence of CMV infections in Croatia. Methods During a 3-year period (2013)(2014)(2015) 2438 consecutive serum samples collected from Croatian residents were tested for the presence of CMV IgM and IgG antibodies using enzyme-linked immunoassay. The IgM/IgG positive samples were further tested for IgG avidity. Results The overall seroprevalence rates for CMV IgG and IgM antibodies were 74.4 % and 4.3 %, respectively. The IgG seroprevalence showed significant differences between population groups: children/ adolescents 54.6 %, general adult population 77.2 %, hemodialysis patients 91.4 % (p < 0.001). Seropositivity of CMV was strongly age-dependent with prevalences ranging from 53.0 % in children less than 10 years old to 93.8 % in persons above 60 years (p < 0.001). There was no difference in the prevalence rate between women with normal pregnancy and women with poor obstetric history. Gender and place of residence were not associated with CMV seropositivity. Using IgG avidity, current/recent primary CMV infection was confirmed by a low/borderline avidity index (AI) in 46.7 % participants, while in 53.3 % a high AI indicated CMV reactivation or reinfection. Primary infections were detected mainly in children and adolescents (83.2 % and 70.5 %, respectively), while reactivation/reinfection was common in persons older than 40 (77.0-100 %). Reactivation/reinfection was most commonly detected in hemodialysis patients (92.3 %). Logistic regression showed that older age and being on hemodialysis were significant predictors of CMV seropositivity. Conclusion Infections with CMV are widespread in the Croatian population. Older age and being on hemodialysis appear to be the main risk factors for CMV infection.
Introduction
Cytomegalovirus (CMV) is a ubiquitous virus with a high worldwide prevalence ranging from 34 -80 % in developed countries to 100 % in some parts of Africa [1, 2] . The virus is transmitted by close personal contact through infected body fluids, usually saliva, urine, blood or genital secretions [3] . Primary CMV infections occur mainly in early childhood or adolescence and are usually asymptomatic in otherwise healthy children and adults. Symptomatic CMV infections are typically manifested as a non-specific febrile disease or a mild self-limiting mononucleosislike syndrome [4] ; however, there are many reports of severe or prolonged symptomatic CMV infections in immunocompetent patients [5] [6] [7] . After primary infection, CMV establishes a lifelong latent infection that can periodically be reactivated [3] . Immunocompromised individuals, such as patients infected with human immunodeficiency virus (HIV), hemodialysis patients and transplant recipients may develop severe CMV disease with a wide spectrum of clinical symptoms including retinitis, hepatitis, colitis, pancreatitis, pneumonitis and encephalitis [8] [9] [10] . In addition, pregnant women also represent a risk group for CMV infections. In seronegative pregnant women, CMV transmission can occur following primary maternal CMV infection. In seropositive women, CMV can cross the placenta during non-primary maternal infection (e.g. reactivation of virus or reinfection with a different strain) resulting in congenital CMV infection [11] . In Europe, there is wide range of CMV seroprevalence among countries and different population groups. Prevalence rates are reported to be 41-92 % in children and adolescents [12] [13] [14] [15] , 45-94 % in general adult populations [14, [16] [17] [18] [19] , 30-91.5 % in pregnant women [20] [21] [22] [23] [24] and 68-99 % in hemodialysis patients [25] [26] [27] .
In Croatia, there are few published studies on the prevalence of CMV infections in selected population groups, such as childbearing-aged women and hemodialysis patients [28, 29] . The aim of this study was to analyze the prevalence of CMV infection in the Croatian general population.
Material and methods
During a 3-year period (January 2013-December 2015), a total of 2438 consecutive serum samples were tested for the presence of CMV-specific IgM and IgG antibodies. Samples were collected from patients residing in all Croatian counties testing at two large medical institutions (Croatian National Institute of Public Health and the Clinical Hospital Center Zagreb). There were 1064 males (43.6 %) and 1374 females (56.4 %) aged from 1 month to 82 years ( Fig. 1) . Patients enrolled in the study were admitted to a routine testing for a preoperative check-up (e.g. cardiac surgery and renal transplant program), elevated liver transaminases, lymphatic disorders, neurological disorders, antenatal and postnatal screening and patients from infertility centers (couples undergoing medically assisted reproduction). Among the pregnant women 238 (76.5 %) had a normal pregnancy and 73 (23.5 %) had a poor obstetric history (e.g. history of intrauterine fetal death, intrauterine growth retardation, stillbirth and habitual abortions).
Anti-CMV IgM and IgG antibodies were detected using a commercial enzyme-linked immunosorbent assay (ELISA, Vircell, Granada, Spain) and an enzymelinked fluorescent assay (ELFA, Vidas, Biomerieux, Marcy l'Etoile, France). Results were interpreted according to the manufacturer's recommendations: Vircell CMV IgM/IgG, antibody index <9 negative, 9-11 equivocal and >11 positive, Vidas CMV IgM <0.70 negative, 0.70-0.90 equivocal and >0.90 positive, CMV IgG <4 aU/ml negative, 4-6 aU/ml equivocal and >6 aU/ml positive (aU = arbitrary units). The IgM/IgG positive samples were further tested for IgG avidity to confirm or to rule out primary CMV infection using ELISA (Euroimmun, Lübeck, Germany) or ELFA (Vidas, Biomerieux).
Statistical analysis
The frequencies are shown with 95 % confidence intervals (CI). Differences between groups were assessed using Fischer's exact test. The strength of association between dependent and independent variables was assessed using logistic regression as crude odds ratios (OR) or odds ratios adjusted for age and gender (AOR). Due to mother-to-child passive immunity, the youngest age group (<6 months) was excluded from logistic regression models. For statistical analysis, software package STATA/IC ver 11.2 (StataCorp LP, College Station, Texas) was used. The level of statistical significance was α = 0.05.
Results
The seroprevalence of CMV IgM/IgG according to the characteristics of participants is presented in Table 1 and CMV IgG antibodies were detected in 1815 (74.4 %) participants. Women were more often seropositive than men (76.3 % vs. 72.0 %, p = 0.015). Of the children aged less than 6 months, 84.4 % were IgG seropositive indicating transplacentally derived maternal antibodies. A significant progressive increase in IgG seroprevalence with age was observed from 53.0 % in children aged 6 months to 9 years up to 93.8 % in persons older than 60 years (p < 0.001). There was no difference in the CMV prevalence among participants residing in urban regions (74.4 %) and participants residing suburban/rural re- According to the population group, seropositivity was lowest in children and adolescents (54.6 %) compared to the general adult population (77.2 %) and hemodialysis patients (91.4 %, p < 0.001). In pregnant women, there was no difference in the prevalence in women with normal pregnancy and poor obstetric history (78.2 % vs. 78.1 %, p = 0.999). Univariate logistic regression showed a steady increase in the strength of association between belonging to an older age group and CMV IgG seropositivity (OR 2.03-13.3). In addition, adult general population and hemodialysis patients had a higher risk for being CMV IgG seropositive compared to children and adolescents (OR 2.82,95% CI 2.28-3.48 and OR 8.83, 95% CI 5.73-13.60, respectively). After standardization for age and gender, being on hemodialysis remained the main predictor of CMV IgG seropositivity (AOR 0.95, 95% CI 1.15-3.41) ( Table 2) .
The presence of CMV IgM antibodies was documented in 105 (4.3 %) participants, IgG avidity was low in 38 (36.2 %) and borderline in 11 (10.5 %) participants indicating current/recent primary CMV infection. In 56 (53.3 %) participants, high IgG avidity was found suggesting CMV reactivation or reinfection. Acute infections were most frequently detected in participants aged 6 months-9 years (7.6 %) and 20-29 years (6.7 %); however, they occurred in all age groups (2.4-4.3 %, p = 0.005) ( Table 1) . Avidity indices (AI) according to age groups are presented in the Fig. 2 . Acute primary infections (low AI) were reported mainly in persons younger than 30 years (83.2 % aged 6 months-9 years, 75.0 % aged 10-19 years, 50.0 % aged 20-29 years). In contrast, the majority of CMV reactivations/reinfections (high AI) were detected in persons above 40 years old (76.9-100 %). According to the population group, acute infections were most common in hemodialysis patients (8.6 %) compared to 5.0 % in children/adolescents and 3.3 % in the general adult population (p < 0.001). Among CMV IgM positive hemodialysis patients, 92.3 % showed a high AI indicating reactivation or reinfection. In children/ adolescents and adult populations the prevalence of current/recent primary infection was 80.0 %/8.0 % and 33.3 %/13.0 %, respectively (Fig. 3) .
Discussion
The results of this first large seroprevalence study have demonstrated a high seroprevalence of CMV infections in the Croatian general population (74.4 %) with significant differences among population groups. Data from European countries showed wide geographical variability. In the general population, seroprevalence in Croatia is comparable to that of Portugal (77 %) [14] . Lower prevalence rates were reported in the Netherlands (45.6 %) [19] , France (49.5 %) [18] , Germany (57.25 %) [17] and Spain (62.8 %) [30] , while Hungary, Turkey and Russia showed higher seroprevalence rates (86 % and 80.9-94.8 %, respectively) [10, 13, 15, 16] .
Several European studies have reported a higher CMV seroprevalence in females, although in most instances these differences were small [19, 30, 31] . Results of this study revealed similar results (76.3 % in females vs. 72.0 % in males). No gender-specific differences were recognized in German adolescents aged 13-16 years [32] .
The CMV seroprevalence in the Croatian population tended to progressively increase with age from 53.0 % in the age groups 6 months to 9 years old up to 93.0 % in participants older than 60 years old. The only exception to this trend was observed in children [10, 15, 18, 19, 33] . Comparing seroprevalence in the similar age groups, some differences were found in children and adolescents. For example, in Portugal the overall seroprevalence rate (77 %) is similar to that of Croatia (74.4 %); however, the seroprevalence in children/ adolescents was higher than in the similar population group in Croatia (64.9-71.3.5 % vs. 53.0-55.4 %) [14] . Moreover, 82.1 % of Turkish children were infected with CMV by the age of 6 years and 92 % by the age of 13 years [13] . Several studies published in the 1990 s and 2000 s reported higher CMV seroprevalence in hemodialysis patients ranging from 83 % to 99.3 % [25, 26, 34] . Croatian hemodialysis patients showed a significantly higher seroprevalence rate (91.4 %) than the general adult population as well (77.2 %). In contrast, a Dutch study found the percentage of CMV seropositive hemodialysis patients within the range of the reported prevalence in the general population [27] . Higher prevalence in hemodialysis patients could be explained by the acquisition of CMV through repeated blood transfusions as well as exposure to CMV through contaminated equipment during hemodialysis procedures. Studies on the prevalence of CMV in childbearingaged, pregnant and parturient women showed seroprevalence rates of 42.3 % in Germany [32] , 49 % in the United Kingdom [35] , 56.3 % in Finland [36] , 57 % in France [22] , 62.4 % in Poland [37] and 91.5-97.3 % in Turkey [24, 38] . Regional differences in CMV seropositivity were observed in Norway (58.5-72.1 %) [23, 39] and Belgium (30-54 %) [21, 31] . A very low prevalence rate was found in Irish pregnant women (30.4 %) [40] . A Russian study reported slightly higher seroprevalence in women with current abortions (81.1 %) compared to women with normal pregnancy (78.0 %) [20] . There was no difference in CMV seropositivity in Croatian pregnant women with normal pregnancy (78.2 %) and pregnant women with poor obstetric history (78.1 %).
The place of residence was not found to be a risk factor for CMV seropositivity in Croatia which is consistent with results from Finland [36] and Turkey [13] .
In this study, IgM antibodies were detected in 4.3 % of participants indicating acute CMV infections. As IgM antibodies could be false positive in some population groups, such as hemodialysis patients and pregnant women, the serological results should be interpreted with caution. The distribution of acute CMV infections in the Croatian population was bimodal. The highest prevalence of acute infections was found in children aged between 6 months and 9 years (7.6 %) and young adults between 20 and 29 years (6.7 %). A high prevalence documented in young children is probably due to starting attending day care centers. A study from Belgium demonstrated that the probability of CMV seroconversion is significantly associated with contact with children aged less than 3 years [31] . In addition to contact with young children, a higher prevalence in young adults could be attributable to sexual CMV transmission.
According to the population group, acute infections were common in hemodialysis patients (8.6 %). Using IgG avidity, recent primary infections (borderline AI) was documented in only 7.7 % patients, while in 92.3 % a high AI indicated CMV reactivation or reinfection.
In conclusion, the results of this study indicate that CMV is widespread in Croatia. More than half of the population (54.6 %) is infected by the age of 20 years. Older age and being on hemodialysis appeared to be main risk factors for CMV infection.
